Summary | Bottom line: iKang's poison pill plan will kill a
hostile offer for the company but could force a management-led
group to raise its earlier bid, while CMGE's China backdoor
listing shows a quickening of the process for US-listed Chinese
companies to return home. The first bidding war for a Chinese
company looking to privatize from ...
hostile offer for the company but could force a management-led
group to raise its earlier bid, while CMGE's China backdoor
listing shows a quickening of the process for US-listed Chinese
companies to return home. The first bidding war for a Chinese
company looking to privatize from ...
youngchinabiz.com | 04 December 2015